Profile
Kristina Kardum is the founder of Kristina Kar, a firm founded in 2019.
She also held former positions as an Alternative Investment Adviser at Julius Bär Gruppe AG from 2015 to 2017, a Research Analyst at Close Brothers Seydler Research AG, and as the Chair (Byron chapter) at Mind Medicine Australia from 2021 to 2023.
Additionally, she served as the Head of Investor Relations at Equity Venture Partners Pty Ltd. Ms. Kardum obtained her undergraduate degree from Macquarie University in 2008 and her graduate degree in 2010.
Kristina Kardum active positions
| Companies | Position | Start |
|---|
Former positions of Kristina Kardum
| Companies | Position | End |
|---|---|---|
Mind Medicine Australia
Mind Medicine Australia Founded in 2018, Mind Medicine Australia is a registered charity dedicated to alleviating mental illness and preventing suicide by expanding treatment options through the safe, clinical use of psychedelic-assisted therapies for conditions such as depression, PTSD, trauma, addictions, and other difficult-to-treat mental illnesses. The private company is based in Melbourne, Australia. The organization offers professional development through its certificate in psychedelic-assisted therapies, provides consulting services to support clinicians in delivering these therapies, and supports research, clinical trials, and legislative advocacy to advance evidence-based psychedelic medicine. Mind Medicine Australia emphasizes education and public engagement, maintains partnerships with government, academia, and regulatory bodies, and fosters a national ecosystem for professional training, patient access, medicine supply, clinical rollouts, and public awareness. | Chairman | 01/08/2023 |
| JULIUS BÄR GRUPPE AG | Consultant / Advisor | 01/08/2017 |
Equity Venture Partners Pty Ltd.
Equity Venture Partners Pty Ltd. Investment ManagersFinance EVP invests in companies located in Australia. The firm focuses on B2B SaaS platforms, software and hardware sectors. It provides financing for early stage capital requirements with an investment size of USD 1 - 5 million. The firm acts as a lead investor and considers co-investments. It also takes a seat on the board of directors. | Public Communications Contact | - |
Close Brothers Seydler Research AG
Close Brothers Seydler Research AG Investment ManagersFinance Provides investment research | Analyst-Equity | - |
Training of Kristina Kardum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Macquarie University
Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Julius Bär Gruppe AG
Julius Bär Gruppe AG Financial ConglomeratesFinance Provides wealth management services | Finance |
Close Brothers Seydler Research AG
Close Brothers Seydler Research AG Investment ManagersFinance Provides investment research | Finance |
Equity Venture Partners Pty Ltd.
Equity Venture Partners Pty Ltd. Investment ManagersFinance EVP invests in companies located in Australia. The firm focuses on B2B SaaS platforms, software and hardware sectors. It provides financing for early stage capital requirements with an investment size of USD 1 - 5 million. The firm acts as a lead investor and considers co-investments. It also takes a seat on the board of directors. | Finance |
Mind Medicine Australia
Mind Medicine Australia Founded in 2018, Mind Medicine Australia is a registered charity dedicated to alleviating mental illness and preventing suicide by expanding treatment options through the safe, clinical use of psychedelic-assisted therapies for conditions such as depression, PTSD, trauma, addictions, and other difficult-to-treat mental illnesses. The private company is based in Melbourne, Australia. The organization offers professional development through its certificate in psychedelic-assisted therapies, provides consulting services to support clinicians in delivering these therapies, and supports research, clinical trials, and legislative advocacy to advance evidence-based psychedelic medicine. Mind Medicine Australia emphasizes education and public engagement, maintains partnerships with government, academia, and regulatory bodies, and fosters a national ecosystem for professional training, patient access, medicine supply, clinical rollouts, and public awareness. |
- Stock Market
- Insiders
- Kristina Kardum
















